Navigation Links
Lipid-Based Drug Delivery in Modern Pharmaceutical Development to be Presented by Catalent and BASF at Forthcoming Workshop
Date:9/22/2018

Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that it will be co-hosting a workshop with BASF Corporation entitled “Revolutionary Then, Relevant Today: Lipid-Based Drug Delivery in Modern Pharmaceutical Development,”. The one-day event is to be held at the Hilton Boston Back Bay hotel, Boston, Massachusetts, on Tuesday, Sept. 25.

The workshop will include scientific presentations from both academic and industry experts. Attendees will develop a better understanding of excipients, lipid-based drug delivery system (LBDDS) formulation development, and softgel technology, to help them overcome development challenges and advance their drug molecules into a drug product.

The presentation topics include:

  • “Early Phase Screening Approach for Lipid Formulations” by Giang (Ellie) Au, Ph.D., Scientist, Product Development, Catalent Pharma Solutions.
  • “Utilizing Crystallization Inhibition to Maximize Drug Bioavailability” by Shaukat Ali, Ph.D., BASF Corporation.
  • “Mechanistic Studies and Modeling to Predict the Impact of Lipids on Oral Absorption” by Rebecca Carrier, Ph.D., Northeastern University.
  • “Bioavailability and Beyond: Innovations in Softgel Formulation and Manufacturing to Advance More Molecules” by Mr. Stephen Tindal, Catalent Pharma Solutions.
  • “Enabling Functional and Modified Drug Release Profiles from Softgel Formulations” by Ashish Joshi, Ph.D., BASF Corporation.

For more information visit https://www.eventbrite.com/e/revolutionary-then-relevant-today-lipid-formulation-for-drug-development-tickets-48575540750

To arrange a meeting with any of the attending Catalent executives at the event, contact Richard Kerns at NEPR - richard@nepr.eu

About BASF Corporation
BASF creates chemistry for a sustainable future offering intelligent solutions to the pharmaceutical industry. With expertise in polymer chemistry, R&D-capabilities and commitment to developing excipients, BASF creates solutions for Instant & Modified Release, Solubilization, Softgels, Skin-Delivery and Biologics. BASF is also a leading supplier of selected APIs including ibuprofen and omega-3. For more information, visit http://www.pharma.basf.com.

About Catalent
Catalent is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products. With 85 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable clinical and commercial product supply. Catalent employs over 11,000 people, including over 1,800 scientists, at more than 30 facilities across five continents, and in fiscal 2018 generated approximately $2.5 billion in annual revenue. Catalent is headquartered in Somerset, New Jersey. For more information, visit http://www.catalent.com.

More products. Better treatments. Reliably supplied.™

Read the full story at https://www.prweb.com/releases/lipid_based_drug_delivery_in_modern_pharmaceutical_development_to_be_presented_by_catalent_and_basf_at_forthcoming_workshop/prweb15766168.htm.


'/>"/>
Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved


Related biology technology :

1. SFC Fluidics, Inc. Receives SBIR Phase II Funding for Development of an Implantable Drug Delivery Device
2. Keystone Nano Announces Progress On RNA Delivery
3. ViaCyte and W. L. Gore & Associates Announce Collaborative Research Agreement to Develop Novel Implantable Delivery Technologies for Cell Therapies
4. Biotech Stocks Under Scanner -- BioDelivery Sciences, Sage Therapeutics, Benitec Biopharma, and OncoGenex Pharma
5. BioDelivery Sciences to Present at the 29th Annual ROTH Conference
6. Global Pharmacovigilance Software Market Analysis 2016 -2022: Focus on End-Users, Delivery Mode, Functionality & Company Profiles - Research and Markets
7. Bioengineering Innovations Show Promise for Improving Treatments and Drug Delivery
8. Lyotropic Delivery Systems Introduces Bio-Enhanced CBD Products
9. Biotech Stocks Under Scanner -- PTC Therapeutics, Arena Pharma, BioDelivery Sciences, and Seres Therapeutics
10. BioDelivery Sciences Provides Corporate Update and Reports Fourth Quarter and Full-Year 2015 Financial Results
11. One Million Solutions in Health & Northeastern University Continue Phase II Partnership to Validate Nanoparticle Technology to Improve Delivery of Poorly Soluble Drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/28/2018)... ... November 28, 2018 , ... Earlier this month, Lajollacooks4u's Founder ... well as experience the height of truffle season. , Her first stop ... countryside. Staying in the exclusive Black Truffle Lodge in the small mountain village of ...
(Date:11/20/2018)... ... November 20, 2018 , ... Each year Forbes receives thousands of nominations for ... outstanding performance by individuals under 30 years of age. The Forbes 30 Under 30 ... and Entertainment to Venture Capital and Science. , In 2017, Visikol CEO Dr. ...
(Date:11/13/2018)... , ... November 12, 2018 , ... ... state-of-the-art practices in Alpharetta and Sandy Springs, now welcomes new patients for MTM® ... discreet and comfortable alternative to traditional braces in the Sandy Springs and Alpharetta ...
(Date:11/9/2018)... ... November 08, 2018 , ... ... Valenzuela, PhD, co-Founder, Chief Executive Officer and President of Andes Biotechnologies, to its ... the world, Dr. Valenzuela brings to uBiome expertise on the genetic studies of ...
Breaking Biology Technology:
(Date:12/5/2018)... VANCOUVER, British Columbia (PRWEB) , ... December 05, ... ... at The Royal Society of Medicine’s Photodynamic Therapy symposium 2018, London, England. The ... and addressed the scientific basis of PDT and its benefits in clinical practice ...
(Date:12/5/2018)... ... December 04, 2018 , ... Urological Associates ... a UroLift® Center of Excellence. The designation recognizes that Dr. Choi has achieved ... a commitment to exemplary care for men suffering from symptoms associated with Benign ...
(Date:11/29/2018)... ... November 29, 2018 , ... ... collaborate with the new NSF Engineering Research Center for Cell Manufacturing Technologies ... together to develop transformative tools and technologies for the consistent, scalable and low-cost ...
Breaking Biology News(10 mins):